Search Results - "Danés, I"

Off-label uses of low-dose Rituximab: a systematic review of the Literature by Fernandez-Martinez, M, Esterlich, E, Vallano, A, Danés, I, Agustí, A

“…Recently, there has been reported that its use in low-dosage might also be effective in approved indications such as rheumatoid arthritis. [...]our objective…”
Get full text

Inquiries about Biotechnological agents over a 15 year period: a descriptive study by Salat, D, Aguilera, C, Asensio, C, Bosch, M, Castañeda, F, Danés, I, Esterlich, E, Llop, R, Vallano, V

Get full text

Therapeutic enquiries about biological agents as a tool to identify safety aspects and patterns of use by Salat, D, Llop, R, Aguilera, C, Danés, I, Bosch, M, Asensio, C, Castañeda, F, Esterlich, E, Vallano, A

“…BackgroundBiotechnological agents (BA) are increasingly being used in clinical practice. We aimed to determine, whether enquiries about them to a therapeutic…”
Get full text

Outcomes of off-label drug uses in hospitals: a multicentric prospective study by Danés, I., Agustí, A., Vallano, A., Alerany, C., Martínez, J., Bosch, J. A., Ferrer, A., Gratacós, L., Pérez, A., Olmo, M., Marron, S. M. Cano, Valderrama, A., Bonafont, X.

“…Purpose The study aims to assess the clinical evidence, outcome and cost of off-label use of medicines in the hospital setting. Methods A multicentric…”
Get full text

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital by Vallano, A., Cereza, G., Pedròs, C., Agustí, A., Danés, I., Aguilera, C., Arnau, J. M.

“…Aim To describe the opinions of hospital physicians concerning problems regarding the spontaneous reporting of adverse drug reactions (ADRs) and ways to solve…”
Get full text

Available evidence and outcome of off-label use of rituximab in clinical practice by Danés, I., Agustí, A., Vallano, A., Martínez, J., Alerany, C., Ferrer, A., López, A., Cortés-Hernández, J., Bosch, J. A.

“…Purpose To analyze the therapeutic indications for off-label use of rituximab, the available evidence for its use, the outcomes, and the cost. Methods This was…”
Get full text

Auditorías en seguridad clínica para centros de atención primaria. Estudio piloto by Ruiz Sánchez, Míriam, Borrell-Carrió, Francisco, Ortodó Parra, Cristina, Fernàndez I Danés, Neus, Fité Gallego, Anna

“…Resumen Objetivo Detectar procesos organizativos, infracciones de normas o actuaciones profesionales que supongan niveles de inseguridad clínica. Diseño…”
Get full text

Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection by Pons, JMV, Tebé, C, Paladio, N, Garcia-Altes, A, Danés, I, Valls-i-Soler, A

“…Aim:  To review respiratory syncytial virus (RSV), passive immunoprophylaxis (PI) trials and meta‐analysis (MA). Methods:  A literature review. Results:  Two…”
Get full text

Auditorías en seguridad clínica para centros de atención primaria. Estudio piloto by Ruiz Sánchez, Míriam, Borrell-Carrió, Francisco, Ortodó Parra, Cristina, Fernàndez I Danés, Neus, Fité Gallego, Anna

Get full text

DNase use in the daily care of cystic fibrosis : who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres by COBOS, N, DANES, I, GARTNER, S, GONZALEZ, M, LINAN, S, ARNAU, J. M

“…Short-term clinical trials with DNase have shown minor to moderate benefits in cystic fibrosis patients. This study was performed to analyse the effectiveness…”
Get full text

Clinical safety audits for primary care centers. A pilot study by Ruiz Sánchez, Míriam, Borrell-Carrió, Francisco, Ortodó Parra, Cristina, Fernàndez I Danés, Neus, Fité Gallego, Anna

“…To identify organizational processes, violations of rules, or professional performances that pose clinical levels of insecurity. Descriptive cross-sectional…”
Get full text

DEC-net, le registre européen des essais cliniques pédiatriques, est une réalité by Jacqz-Aigrain, E., Zarrabian, S., Pandolfini, C., Bonati, M., Sammons, H., Choonara, I., Danés, I., Fuentes, I., Arnau, J.

Get full text

Efficacy and safety of low molecular weight heparin in the treatment of pulmonary thromboembolism by Cereza, G, Danés, I

Get more information

DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres. DNase National Study Group by Cobos, N, Danés, I, Gartner, S, González, M, Liñán, S, Arnau, J M

“…Short-term clinical trials with DNase have shown minor to moderate benefits in cystic fibrosis patients. This study was performed to analyse the effectiveness…”
Get full text

Syndrome of hypersensitivity by antiepileptic drugs by Durán, M, Danés, I

Get more information

New antibiotic therapies for acute pharyngotonsillitis by Rodríguez, D, Danés, I

Get more information

Actualización en el tratamiento de la hipertensión arterial by Diogène, E., Llop, R., Danés, I., Arnau, J.M.

Get full text

Inhaled glucocorticoids and their effects on growth in children by Danés, I, Agustí, A

Get more information

A European clinical trial register in the pediatric field: DEC-net by Jacqz-Aigrain, E, Zarrabian, S, Pandolfini, C, Bonati, M, Sammons, H, Choonara, I, Danés, I, Fuentes, I, Arnau, J

Get full text

Safety of quinolones administration in children? by Danés, I, Arnau, J M

Get more information